A typical case of granulomatous uveitis
DOI:
https://doi.org/10.65636/cjo.v53i2.7127Keywords:
granulomatous uveits, mutton-fat keratic precipitates, endothelial neovascularization, vitreous bodiesAbstract
Grcmulomatous uveitis is not tbe most impressive of current eye diseases, but its effects on the cornea - keratic precipitates, neovascularizatlon and scarring - are serious. Early diagnosis and treatment are the only ways to handle this kind of disease, thus allowing only minor long-term effects to be dealt with. That treatment includes steroid therapy and regular follow-up in order to minimize side effects.
References
1. Schlagel JF Jr. Etiologic diagnosis of uveitis. In: Duane TD. ed. Clinical Opluhalrnology, vol. 4(41). Hagerstown. MD: Harper & Row, 1976: 1-7.
2. Woods AC. Endogenous inflammation of the uveal tract. Baltimore: Williams and Wilkins, 1989.
3. Nursenblan RB. Palestine AG. Uveitis: fundamentals and clinical practice. Chicago: Yearbook Medical Publishers. 1989.
4. Bachman DM, Rosenthal AR, Beckingsale AB. Granulomalous uveitis in neurological disease. Br J Ophthalmol 1985:69:192-96. DOI: https://doi.org/10.1136/bjo.69.3.192
5. Rao NA. Marak GE Jr. Experimental granulomatous uveitis: an electronic microscopic study of pigment-containing giant cells. lnvest Ophthalmol Vis Sci 1985 Sep:26(9): 1303-5.
6. Marak GE Jr. Recent advances in sympathetic ophthalmia. Surv Ophthalmol 1979:24:141. DOI: https://doi.org/10.1016/0039-6257(79)90018-3
7. Wagner AL, Crouch ER Jr. Valone JA Jr. Acute orbital pseudotumor with iatrogenic intraorbital air: a diagnosis dilemma. J Pedi.atr Ophthalmol Strabismus 1986:23(6):292-97. DOI: https://doi.org/10.3928/0191-3913-19861101-10
8. Manuello JA, Flanagan JC. Management of orbiral inflamrnatory disease: a protocol. Surv Ophthalmol 1984:29: 104-16. DOI: https://doi.org/10.1016/0039-6257(84)90167-X
9. Campinchi R, Fuascn JP, Bloch ME. Haut J. L'Uveite, phenomene immunologique et allergique. Paris: Masson, 1970.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
